Xeris Pharmaceuticals | Lånekapital



Loan Capital Endring Dato
Adcock Ingram Holdings ZAR 238.08M 21.45M 2024-06
Celltrion KRW 79.58B 21.94B 2024-09
Cspc Pharmaceutical CNY 66.32M 40.74M 2024-06
Dianthus Therapeutics USD 0 0 2024-09
Ecofibre AUD 9.5M 0 2024-06
Eli Lilly USD 28.53B 518.3M 2024-12
Kangmei Pharma CNY 169.19M 7.26M 2024-09
Knight Therapeutics CAD 36.51M 2.04M 2024-09
Laboratorios Farma EUR 98.14M 45.9M 2024-06
Malin Corporation EUR 0 0 2024-06
Medical Developments International AUD 1.91M 146K 2024-06
Neuren Pharmaceuticals AUD 0 0 2024-12
Organigram Holdings CAD 43.29M 12.19M 2024-12
Pacira USD 383.54M 2.35M 2024-12
Perrigo USD 3.58B 730.9M 2024-12
Pharma Mar EUR 41.23M 999K 2024-12
Qiagen NV USD 1.34B 26.51M 2024-12
Sartorius EUR 4.43B 106.8M 2024-09
Sino Biopharmaceutical CNY 1.16B 90.25M 2024-06
Supernus Pharmaceuticals USD 0 0 2024-12
Tilray USD 316.63M 15.02M 2024-11
Zz Pientze Pharmaceu 162.42M 4.3M 2024-09



Xeris Pharmaceuticals Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.